BAJAJFINSV vs DRREDDY: Stock Comparison

Bajaj Finserv Ltd vs Dr Reddys Laboratories LtdUpdated 25 Aug 26, 3:14 PM ISTNSE & company filings

Bajaj Finserv Ltd is the larger company by market capitalisation. Bajaj Finserv Ltd shows a higher ROE and faster revenue growth, while Dr Reddys Laboratories Ltd shows a lower P/E, a higher dividend yield and a higher ROCE. These are relative readings on individual metrics — weigh valuation against growth, margins, leverage and capital efficiency rather than treating any single number as decisive.

Metric snapshot

BAJAJFINSV leads 7; DRREDDY leads 5 of 12

Not a rating
These companies operate in different sectors (Financial Services vs Healthcare). Valuation and leverage norms differ across sectors, so cross-sector ratio comparisons can mislead — compare each against its own sector peers too.

Interactive comparison

Compare the numbers that shape the decision

Every row uses its own scale. Switch lenses to compare like with like.

BAJAJFINSVDRREDDY

Valuation lens

What price are you paying?

Market CapContext only
₹3.21 L Cr
₹99,410 Cr
P/E RatioDRREDDY has the lower reading
31.59x
30.94x
P/B RatioDRREDDY has the lower reading
4.12x
2.63x
EPSBAJAJFINSV has the higher reading
₹62.25
₹39.7
Book ValueContext only
₹487.35
₹460.31
Dividend YieldDRREDDY has the higher reading
0.06%
0.68%

✓ marks the usual favourable reading; it is not a recommendation.

Key Differences

Market Cap
BAJAJFINSV is the larger company
₹3.21 L Cr vs ₹99,410 Cr
P/E Ratio
DRREDDY has a lower P/E
30.94x vs 31.59x
P/B Ratio
DRREDDY has a lower P/B
2.63x vs 4.12x
EPS
BAJAJFINSV has higher earnings per share
₹62.25 vs ₹39.7
Dividend Yield
DRREDDY has a higher dividend yield
0.68% vs 0.06%
Revenue Growth (TTM YoY)
BAJAJFINSV has faster revenue growth
5.3% vs -11.6%
EPS Growth (TTM YoY)
BAJAJFINSV has faster EPS growth
5.7% vs -86.2%
Qtr Sales Growth
BAJAJFINSV has stronger quarterly sales growth
5.19% vs -11.5%

Each difference is a single, relative reading — StockeZee does not name an overall winner.

Profile

MetricBAJAJFINSVDRREDDY
SectorFinancial ServicesHealthcare
IndustryHolding CompanyPharmaceuticals

Price

MetricBAJAJFINSVDRREDDY
Live Price₹1,999₹1,190
Day Change-0.13%0%
Volume3.7 L14.93 L
52-Week High₹2,195₹1,414.9
52-Week Low₹1,597₹1,101
Distance from 52W High-8.93%-15.9%

Valuation

MetricBAJAJFINSVDRREDDY
Market Cap₹3.21 L Cr₹99,410 Cr
P/E Ratio31.59x30.94x
P/B Ratio4.12x2.63x
EPS₹62.25₹39.7
Book Value₹487.35₹460.31
Dividend Yield0.06%0.68%

Growth

MetricBAJAJFINSVDRREDDY
Revenue Growth (TTM YoY)5.3%-11.6%
EPS Growth (TTM YoY)5.7%-86.2%
Qtr Sales Growth5.19%-11.5%
Qtr Profit Growth5.05%-86.1%

Profitability & Leverage

Debt-to-equity is shown for reference only — it is not a like-for-like metric for banks and financials.
MetricBAJAJFINSVDRREDDY
ROE13.2%11.2%
ROCE10.6%13%
Net Margin7.66%12.76%
Operating Margin37.9%19.2%
Debt to Equity5.52x0.2x

Shareholding

As of Jun 2026 • change vs previous quarter
MetricBAJAJFINSVDRREDDY
Promoter Holding58.7%26.64% 0.01 pp
FII Holding6.91% 0.33 pp32.07% 1.01 pp
DII Holding12.1% 0.34 pp31.74% 1.02 pp
Public Holding22.23% 0.07 pp9.35% 0.02 pp

How to Read This Comparison

Valuation ratios (P/E, P/B) use the latest consolidated figures where available; growth numbers compare against the same period last year; shareholding percentages come from the most recent quarterly filings, with the change shown against the prior quarter. A "more favourable" highlight is relative between these two companies only — it is not a rating, a recommendation, or a comparison against the wider sector. Rows with no reported data for either company are hidden rather than shown empty.

Deep-dive each company on its stock page for quarterly results, technicals, filings and the full peer set: Bajaj Finserv Ltd and Dr Reddys Laboratories Ltd.

Data source: NSE and company filings via StockeZee. This comparison is informational — it is not investment advice, and StockeZee is not a SEBI-registered investment adviser.